ARS Pharmaceuticals, Inc. (SPRY)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Justin Chakma
|
Chief Business Officer | 682.7k | -- | 1990 |
|
Mr. Donn Casale
|
CEO, President & Director | -- | -- | 1973 |
|
Dr. Robert Bell Ph.D.
|
Co-Founder & Chief Science Officer | -- | -- | -- |
|
Ms. Kathleen D. Scott CPA
|
Chief Financial Officer | -- | -- | -- |
|
Mr. Brian T. Dorsey M.S.
|
Chief Operating Officer | 706.97k | -- | 1969 |
|
Mr. Alexander A. Fitzpatrick Esq.
|
Chief Legal Officer & Secretary | 677.14k | -- | 1967 |
|
Mr. Daniel Relovsky
|
Senior Vice President of Marketing | -- | -- | -- |
|
Ms. Lynda Harris
|
Vice President of Human Resources | -- | -- | -- |
|
Mr. Eric Karas
|
Chief Commercial Officer | 618.61k | -- | 1973 |
ARS Pharmaceuticals, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 195
Description
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Corporate Governance
Upcoming Events
November 5, 2026 at 8:00 PM UTC
ARS Pharmaceuticals, Inc. Earnings Date
